A political battle continues within the U.S. government over renewing expired Affordable Care Act (ACA) subsidies. The soaring cost of healthcare, even for those with private insurance, has become a ...

In recent months, UnitedHealth Group has raised premiums by around 20–30%, updated its 2025 earnings guidance, and faced ...

Shares of the healthcare giant are still down more than 30% year to date, after plunging as much as 53% at one point. Should ...

UnitedHealth Group has agreed to sell its last South American business Banmedica to Brazilian private equity group Patria Investments for $1 billion, two sources with knowledge of the matter said on ...

Discover why UnitedHealth stock rebounded after a sharp decline, future growth prospects, and how strategic changes may offer ...

Mairs & Power, an investment advisor, released the third-quarter 2025 investor letter for the “Mairs & Power Balanced Fund.” A copy of the letter can be downloaded here. As we move into 2025, the ...

UnitedHealth Group stock is a top dividend growth stock with solid returns, reliable yield, and long-term growth prospects.

UnitedHealth's decision to exit 100-plus Medicare Advantage plans was a prudent move. The stock could have significant upside potential as its bottom line improves. One key wild card for UnitedHealth, ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. UnitedHealth Group profits fell to $3.4 billion in the second quarter as ...

UnitedHealth Group, the company that owns healthcare conglomerate UnitedHealth, said on Thursday that it is cooperating with the federal government as it fields criminal and civil requests from ...

Former UnitedHealth Group CEO William McGuire joins mediation team for Fairview and University of Minnesota merger negotiations.

UnitedHealth Group Inc. defeated an insurance reimbursement suit Tuesday after a federal appeals court affirmed the Employee ...